Decreasing heart rate in heart failure: pros and cons

被引：1

作者：

Natale, Enrico ^{[1
]}

Marsocci, Alfiera ^{[2
]}

机构：

[1] San Camillo Hosp, Cardiol Unit 1, Rome, Italy

[2] Policlin Luigi Liegro, Med Unit, Rome, Italy

来源：

JOURNAL OF CARDIOVASCULAR MEDICINE | 2018年 / 19卷

关键词：

-blockers; heart failure; HR; ivabradine; CORONARY-ARTERY-DISEASE; VENTRICULAR SYSTOLIC DYSFUNCTION; RATE REDUCTION; SUBGROUP ANALYSIS; CONTROLLED-TRIAL; RISK-FACTOR; OUTCOMES; IVABRADINE; BEAUTIFUL; REGISTRY;

D O I：

10.2459/JCM.0000000000000564

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E96 / E98

页数：3

共 14 条

[1] Böhm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7
[2] The Notch pathway: a novel target for myocardial remodelling therapy?
Ferrari, Roberto
Rizzo, Paola
[J]. EUROPEAN HEART JOURNAL, 2014, 35 (32) : 2140 - U86
[3] Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers
Flannery, Genevieve
Gehrig-Mills, Rosie
Billah, Baki
Krum, Henry
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (06) : 865 - 869
[4] Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
Fox, Kim
Ford, Ian
Steg, P. Gabriel
Tendera, Michal
Robertson, Michele
Ferrari, Roberto
[J]. LANCET, 2008, 372 (9641) : 817 - 821
[5] Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure
Fox, Kim
Ford, Ian
Steg, Philippe Gabriel
Tardif, Jean-Claude
Tendera, Michal
Ferrari, Roberto
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (12) : 1091 - 1099
[6] Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial
Fox, Kim
Ford, Ian
Steg, Ph. Gabriel
Tendera, Michal
Robertson, Michele
Ferraris, Roberto
[J]. EUROPEAN HEART JOURNAL, 2009, 30 (19) : 2337 - 2345
[7] HEART-RATE AND CARDIOVASCULAR MORTALITY - THE FRAMINGHAM-STUDY
KANNEL, WB
KANNEL, C
PAFFENBARGER, RS
CUPPLES, LA
[J]. AMERICAN HEART JOURNAL, 1987, 113 (06) : 1489 - 1494
[8] STUDIES OF BLOOD PRESSURE IN ARMY OFFICERS .4. TRANSIENT TACHYCARDIA - PROGNOSTIC SIGNIFICANCE ALONE AND IN ASSOCIATION WITH TRANSIENT HYPERTENSION
LEVY, RL
WHITE, PD
STROUD, WD
HILLMAN, CC
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1945, 129 (09): : 585 - 588
[9] Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
Maggioni, Aldo P.
Anker, Stefan D.
Dahlstrom, Ulf
Filippatos, Gerasimos
Ponikowski, Piotr
Zannad, Faiez
Amir, Offer
Chioncel, Ovidiu
Leiro, Marisa Crespo
Drozdz, Jaroslaw
Erglis, Andrejs
Fazlibegovic, Emir
Fonseca, Candida
Fruhwald, Friedrich
Gatzov, Plamen
Goncalvesova, Eva
Hassanein, Mahmoud
Hradec, Jaromir
Kavoliuniene, Ausra
Lainscak, Mitja
Logeart, Damien
Merkely, Bela
Metra, Marco
Persson, Hans
Seferovic, Petar
Temizhan, Ahmet
Tousoulis, Dimitris
Tavazzi, Luigi
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (10) : 1173 - 1184
[10] Meta-analysis: beta-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
McAlister, Finlay A.
Wiebe, Natasha
Ezekowitz, Justin A.
Leung, Alexander A.
Armstrong, Paul W.
[J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (11) : 784 - W141

← 1 2 →